Skip to main content

Table 1 Characteristics of the study population at baseline, and details of follow-up, according to alcohol intake

From: Alcohol consumption and cancer incidence in women: interaction with smoking, body mass index and menopausal hormone therapy

 

Alcohol intake (drinks/week)

1–2

3–6

7–14

 ≥ 15

No. of women, n

292,249

209,275

230,749

62,848

Alcohol intake mean drinks/week (SD)a

2.6 (3.0)

5.5 (4.1)

10.0 (5.6)

17.0 (8.6)

Age, mean (SD)

56.7 (4.8)

56.3 (4.8)

56.1 (4.7)

55.8 (4.6)

Most deprived quintile, % (n)

17 (49,191)

17 (34,716)

16 (36,832)

16 (9,788)

No educational qualifications, % (n)

41 (117,865)

37 (76,584)

33 (74,749)

28 (17,625)

Current smoker, % (n)

16 (46,810)

18 (38,445)

22 (51,638)

26 (16,402)

Body mass index (kg/m2), mean (SD)

26.3 (4.6)

25.8 (4.2)

25.4 (4.0)

25.4 (4.1)

Current use menopausal hormones, % (n)

33 (96,504)

36 (74,486)

38 (87,214)

39 (24,432)

Ever use oral contraceptives, % (n)

59 (172,254)

64 (133,527)

69 (157,458)

73 (45,732)

Strenuous exercise > once per week, % (n)

20 (56,481)

23 (45,930)

25 (56,672)

28 (16,926)

Follow-up

Person-years

4,992,142

3,552,867

3,873,456

1,030,747

Years of follow-up per woman

17.1

17.0

16.8

16.4

No. of cancers

50,555

36,139

41,325

12,184

  1. amean alcohol intake (drinks/week) in each category is the re-measured value taken on average 7.8 years after baseline